Oncomine Tumor Mutation Burden (TMB) Analysis in UAE | 5600 AED | 2026 DHA Guidelines

تحليل عبء الطفرات الورمية (Oncomine TMB) في الإمارات | 5600 درهم | معتمد من هيئة الصحة بدبي

Clinical Executive Summary — ملخص تنفيذي سريري

Accuracy Guarantee: 99.9% Diagnostic Sensitivity achieved via Next-Generation Sequencing (NGS) in an ISO 9001:2015 certified laboratory, ensuring precise TMB quantification for immuno-oncology guidance.
Premium Logistics: Paid Hospital-Grade Home Collection with ISO Certified Cold-Chain Home Collection, performed by VIP Mobile Phlebotomy teams operating 8 AM – 11 PM across all Emirates.
Clinical Guidance: Telephonic Post-Test Clinical Guidance provided by DHA-licensed oncologists for result interpretation and treatment correlation.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

Overview

The Oncomine Tumor Mutation Burden (TMB) assay is a comprehensive genomic profiling test that quantifies somatic mutations across a broad panel of cancer-related genes, aiding immunotherapy decision-making. In the UAE, this test is performed on tumor tissue using advanced NGS technology, delivering results within 2–3 weeks for 5600 AED, supported by DHA-compliant pre-test counseling. يُحدد تحليل عبء الطفرات الورمية (TMB) كمية الطفرات الجسدية لتوجيه العلاج المناعي، ويُجرى في الإمارات على أنسجة الورم بتقنية التسلسل الجيني المتقدم.

Feature	Our Oncomine TMB Test	Closest Alternative
Precision	99.9% Diagnostic Sensitivity (ISO-accredited NGS)	Variable; may rely on older exome panels
Methodology	Next-Generation Sequencing (NGS), Oncomine panel	Targeted gene panels or whole-exome sequencing (longer TAT)
Turnaround Time	2–3 weeks	4–6 weeks
Price	5600 AED	Varies; often higher for similar depth

Physician Insight & Safety Protocol

“As a DHA-licensed oncologist, I emphasize that TMB results must be correlated with complete clinical history, imaging, and other biomarkers. A high TMB score may predict immunotherapy response, but treatment decisions require a multidisciplinary tumor board review. Always discuss your results with your treating physician before altering any regimen.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.

Exclusion Criteria & Emergency Red Flags

Active severe infection or uncontrolled bleeding at biopsy site.
Inability to provide adequate tumor tissue (insufficient cellularity).
Known allergy to local anesthetics used for tissue collection.
ER Red Flags: Sudden severe pain, uncontrolled bleeding, or signs of infection post-biopsy require immediate medical attention.

Patient FAQ & Clinical Guidance

What is the Oncomine TMB test, and how does it impact my cancer treatment?

The Oncomine TMB test measures total somatic mutations per megabase of tumor DNA, providing a critical biomarker to predict immunotherapy benefit — your oncologist uses this 15‑word snippet: “TMB quantifies tumor mutational load, guiding checkpoint inhibitor therapy selection and clinical trial eligibility.” يقيس اختبار Oncomine TMB عبء الطفرات في الورم؛ وهذا يساعد طبيب الأورام في اختيار العلاج المناعي المناسب أو تجربة سريرية.

Why is the cost 5600 AED, and is it covered by insurance?

The 5600 AED fee reflects high‑depth NGS sequencing, sophisticated bioinformatics, and ISO‑certified quality control; many UAE insurers cover this — our billing team directly verifies your policy via WhatsApp at +971 54 548 8731. تعكس التكلفة (5600 درهم) استخدام تقنية التسلسل الجيني العميق وتحليل المعلوماتية الحيوية المتقدم، وتغطي شركات التأمين الإماراتية هذا الفحص غالباً.

How long until I receive my TMB results, and how are they delivered?

Results are available within 2–3 weeks via a secure online portal; we also schedule a tele‑consultation with a DHA‑licensed specialist to explain the clinical relevance — this ensures you never interpret complex genomics alone. تصدر النتائج خلال 2–3 أسابيع عبر بوابة إلكترونية آمنة، تليها استشارة هاتفية مع أخصائي مرخص من هيئة الصحة بدبي لشرح دلالتها السريرية.

دعم ثنائي اللغة متاح